|
|
| G
|
Aaas
|
aladin WD repeat nucleoporin
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of AAAS mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
decreases expression increases expression multiple interactions increases activity
|
ISO EXP
|
2-Acetylaminofluorene results in decreased expression of ABCB1 mRNA 2-Acetylaminofluorene results in increased expression of ABCB1 mRNA; 2-Acetylaminofluorene results in increased expression of ABCB1A mRNA lipopolysaccharide, E coli O55-B5 inhibits the reaction [2-Acetylaminofluorene results in increased expression of ABCB1A mRNA] 2-Acetylaminofluorene results in increased expression of ABCB1 mRNA; 2-Acetylaminofluorene results in increased expression of ABCB1 protein Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA]; Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 protein] 2-Acetylaminofluorene results in increased activity of ABCB1 protein [2-Acetylaminofluorene results in increased activity of AKT1 protein] which results in increased expression of ABCB1 mRNA; [2-Acetylaminofluorene results in increased activity of RAC1 protein] which results in increased expression of ABCB1 mRNA; [RELA protein binds to NFKB1 protein] affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA]
|
CTD |
PMID:11170838 PMID:11960367 PMID:12387747 PMID:17303067 PMID:17669244 PMID:21784091 PMID:22213190 More...
|
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
increases expression multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased expression of ABCB1B mRNA; 2-Acetylaminofluorene results in increased expression of ABCB1B protein [2-Acetylaminofluorene results in increased abundance of Reactive Oxygen Species] which results in increased expression of ABCB1B mRNA; lipopolysaccharide, E coli O55-B5 inhibits the reaction [2-Acetylaminofluorene results in increased expression of ABCB1B mRNA]; RELA protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1B mRNA]
|
CTD |
PMID:11020383 PMID:11170838 PMID:12801967 PMID:17070881 PMID:22084566 |
|
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567
|
|
| G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ABCC1 mRNA
|
CTD |
PMID:12801967 PMID:17669244 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
|
|
| G
|
Abcc10
|
ATP binding cassette subfamily C member 10
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of ABCC10 mRNA
|
CTD |
PMID:12566991 |
|
NCBI chr 9:22,154,811...22,174,743
Ensembl chr 9:22,154,804...22,174,743
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
increases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased expression of ABCC2 mRNA NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCC2 mRNA] 2-Acetylaminofluorene results in increased expression of ABCC2 mRNA; 2-Acetylaminofluorene results in increased expression of ABCC2 protein
|
CTD |
PMID:10691972 PMID:16381673 PMID:16426233 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
increases expression
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of ABCC3 mRNA; 2-Acetylaminofluorene results in increased expression of ABCC3 protein
|
CTD |
PMID:10691972 PMID:12801967 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
|
|
| G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
increases expression increases activity multiple interactions
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of ABCG2 mRNA 2-Acetylaminofluorene results in increased activity of ABCG2 protein 2-Acetylaminofluorene results in increased expression of ABCG2 mRNA; 2-Acetylaminofluorene results in increased expression of ABCG2 protein NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCG2 mRNA]
|
CTD |
PMID:12819005 PMID:16381673 PMID:17538966 PMID:17669244 PMID:27475308 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
| G
|
Acaa2
|
acetyl-CoA acyltransferase 2
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of ACAA2 mRNA
|
CTD |
PMID:14656948 |
|
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
|
|
| G
|
Acmsd
|
aminocarboxymuconate semialdehyde decarboxylase
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of ACMSD mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr13:41,752,894...41,798,427
Ensembl chr13:41,752,875...41,798,427
|
|
| G
|
Acot9
|
acyl-CoA thioesterase 9
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ACOT9 mRNA
|
CTD |
PMID:21784091 |
|
NCBI chr X:43,922,943...43,973,311
Ensembl chr X:43,914,923...43,973,205
|
|
| G
|
Acsl3
|
acyl-CoA synthetase long-chain family member 3
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ACSL3 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
|
|
| G
|
Aen
|
apoptosis enhancing nuclease
|
increases expression
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of AEN mRNA
|
CTD |
PMID:17070881 PMID:21607683 PMID:22584684 |
|
NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898
|
|
| G
|
Afp
|
alpha-fetoprotein
|
multiple interactions increases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Carbon Tetrachloride] affects the expression of AFP protein; [2-Acetylaminofluorene co-treated with Choline deficiency] results in increased expression of AFP protein 2-Acetylaminofluorene results in increased expression of AFP mRNA; 2-Acetylaminofluorene results in increased expression of AFP protein
|
CTD |
PMID:6187438 PMID:11350689 PMID:11813887 PMID:15133858 PMID:17538966 |
|
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of AHR mRNA
|
CTD |
PMID:25224404 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Ak1
|
adenylate kinase 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of AK1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Akr1b1
|
aldo-keto reductase family 1 member B1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of AKR1B1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315
|
|
| G
|
Akr1b10
|
aldo-keto reductase family 1 member B10
|
multiple interactions increases expression
|
EXP ISO
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1B10 mRNA 2-Acetylaminofluorene results in increased expression of AKR1B10 mRNA
|
CTD |
PMID:14656948 PMID:26198647 |
|
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847
|
|
| G
|
Akr1c12
|
aldo-keto reductase family 1, member C12
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of AKR1C12 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1C12 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr17:70,955,288...70,971,412
Ensembl chr17:70,955,294...70,971,431
|
|
| G
|
Akr7a3
|
aldo-keto reductase family 7 member A3
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of AKR7A3 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein; [2-Acetylaminofluorene results in increased activity of AKT1 protein] which results in increased expression of ABCB1 mRNA 2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein; Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein]
|
CTD |
PMID:11960367 PMID:17303067 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alb
|
albumin
|
multiple interactions increases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Choline deficiency] results in increased expression of ALB protein 2-Acetylaminofluorene results in increased expression of ALB protein
|
CTD |
PMID:6187438 PMID:15133858 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Aldh1a1
|
aldehyde dehydrogenase 1 family, member A1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ALDH1A1 mRNA; 2-Acetylaminofluorene results in increased expression of ALDH1A1 protein
|
CTD |
PMID:17070881 PMID:22584684 PMID:33211169 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
|
|
| G
|
Aldh1a3
|
aldehyde dehydrogenase 1 family, member A3
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ALDH1A3 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777
|
|
| G
|
Aldh3a1
|
aldehyde dehydrogenase 3 family, member A1
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ALDH3A1 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151
|
|
| G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein]; Tocotrienols affects the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein]
|
CTD |
PMID:15548946 PMID:15554553 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
|
|
| G
|
Anapc11
|
anaphase promoting complex subunit 11
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of ANAPC11 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr10:106,373,610...106,384,633
Ensembl chr10:106,373,634...106,384,633
|
|
| G
|
Anxa3
|
annexin A3
|
increases expression multiple interactions
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of ANXA3 mRNA [Carbon Tetrachloride co-treated with 2-Acetylaminofluorene] results in increased expression of ANXA3 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ANXA3 mRNA]
|
CTD |
PMID:17317680 PMID:18071240 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
| G
|
Anxa8
|
annexin A8
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of ANXA8 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310
|
|
| G
|
Aox1
|
aldehyde oxidase 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of AOX1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AOX1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980
|
|
| G
|
Apoa2
|
apolipoprotein A2
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of APOA2 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410
|
|
| G
|
Apoa4
|
apolipoprotein A4
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of APOA4 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
|
|
| G
|
Apoc3
|
apolipoprotein C3
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of APOC3 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679
|
|
| G
|
Apod
|
apolipoprotein D
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of APOD mRNA
|
CTD |
PMID:20713471 |
|
NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263
|
|
| G
|
Aqp5
|
aquaporin 5
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of AQP5 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062
|
|
| G
|
Areg
|
amphiregulin
|
increases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased expression of AREG mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of AREG mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641
|
|
| G
|
Asgr1
|
asialoglycoprotein receptor 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of ASGR1 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr10:55,274,299...55,278,323
Ensembl chr10:55,274,706...55,278,322
|
|
| G
|
Atp6v1d
|
ATPase H+ transporting V1 subunit D
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ATP6V1D mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
ISO EXP
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of BAX mRNA] [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein] 2-Acetylaminofluorene results in increased expression of BAX mRNA
|
CTD |
PMID:11915028 PMID:17070881 PMID:17317680 PMID:19167416 PMID:21607683 PMID:22584684 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions increases expression
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein] 2-Acetylaminofluorene results in increased expression of BCL2 mRNA
|
CTD |
PMID:11915028 PMID:19167416 PMID:22213190 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
multiple interactions increases expression
|
EXP ISO
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein] 2-Acetylaminofluorene results in increased expression of BCL2L1 mRNA
|
CTD |
PMID:11915028 PMID:21607683 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of BIRC5 mRNA
|
CTD |
PMID:19167416 PMID:22213190 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Brca1
|
BRCA1, DNA repair associated
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of BRCA1 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763
|
|
| G
|
Btg2
|
BTG anti-proliferation factor 2
|
increases expression
|
EXP ISO
|
2-Acetylaminofluorene results in increased expression of BTG2 mRNA
|
CTD |
PMID:17070881 PMID:21607683 |
|
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
| G
|
Bzw1
|
basic leucine zipper and W2 domains 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of BZW1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684
|
|
| G
|
C4bpa
|
complement component 4 binding protein, alpha
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of C4BPA mRNA
|
CTD |
PMID:16510358 |
|
NCBI chr13:44,627,959...44,663,552
Ensembl chr13:44,627,982...44,663,471
|
|
| G
|
C6
|
complement C6
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of C6 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:55,573,653...55,649,120
|
|
| G
|
C7
|
complement C7
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of C7 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:55,816,807...55,892,672
|
|
| G
|
Cacna2d1
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CACNA2D1 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:19,905,764...20,330,147
|
|
| G
|
Cadm1
|
cell adhesion molecule 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CADM1 protein
|
CTD |
PMID:17326163 |
|
NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192
|
|
| G
|
Car2
|
carbonic anhydrase 2
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CAR2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CAR2 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases activity increases expression
|
EXP
|
2-Acetylaminofluorene inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactosamine] results in increased cleavage of CASP3 protein]; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP3 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of CASP3 protein]
|
CTD |
PMID:12907702 PMID:23665045 PMID:26364502 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp7
|
caspase 7
|
multiple interactions increases activity
|
EXP
|
Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP7 protein]
|
CTD |
PMID:23665045 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp9
|
caspase 9
|
increases activity increases expression multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased activity of CASP9 protein 2-Acetylaminofluorene results in increased expression of CASP9 protein Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of CASP9 protein]
|
CTD |
PMID:23665045 PMID:26364502 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
multiple interactions decreases expression decreases activity
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of CAT protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of CAT protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in decreased activity of CAT protein]
|
CTD |
PMID:17761372 PMID:23665045 PMID:26364502 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cavin3
|
caveolae associated protein 3
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CAVIN3 mRNA
|
CTD |
PMID:14656948 |
|
NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:169,238,384...169,239,981
|
|
| G
|
Cblc
|
Cbl proto-oncogene C
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CBLC mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 1:88,567,930...88,584,709
Ensembl chr 1:88,567,932...88,584,709
|
|
| G
|
Cbr1
|
carbonyl reductase 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of CBR1 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104 Ensembl chr11:46,378,411...46,381,104
|
|
| G
|
Cck
|
cholecystokinin
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of CCK mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:130,031,013...130,037,686
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
affects expression
|
EXP
|
2-Acetylaminofluorene affects the expression of CCL2 mRNA; 2-Acetylaminofluorene affects the expression of CCL2 protein
|
CTD |
PMID:25051504 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl7
|
C-C motif chemokine ligand 7
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CCL7 protein
|
CTD |
PMID:25051504 |
|
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
increases expression multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased expression of CCN2 mRNA; 2-Acetylaminofluorene results in increased expression of CCN2 protein Iloprost inhibits the reaction [2-Acetylaminofluorene results in increased expression of CCN2 mRNA]
|
CTD |
PMID:15940639 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Ccna2
|
cyclin A2
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of CCNA2 protein
|
CTD |
PMID:15158336 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnb1
|
cyclin B1
|
decreases expression increases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of CCNB1 protein 2-Acetylaminofluorene results in increased expression of CCNB1 mRNA
|
CTD |
PMID:15158336 PMID:22584684 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnb2
|
cyclin B2
|
increases expression multiple interactions
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of CCNB2 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CCNB2 mRNA]
|
CTD |
PMID:17317680 PMID:19167416 PMID:22584684 |
|
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
|
|
| G
|
Ccnd1
|
cyclin D1
|
multiple interactions increases expression
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCND1 mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCND1 mRNA] 2-Acetylaminofluorene results in increased expression of CCND1 mRNA
|
CTD |
PMID:14633663 PMID:22584684 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccne1
|
cyclin E1
|
multiple interactions decreases activity
|
EXP
|
2-Acetylaminofluorene inhibits the reaction [CDK2 protein binds to CCNE1 protein]; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCNE1 mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCNE1 mRNA] 2-Acetylaminofluorene results in decreased activity of CCNE1 protein
|
CTD |
PMID:10708481 PMID:14633663 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Ccng1
|
cyclin G1
|
decreases expression increases expression
|
EXP ISO
|
2-Acetylaminofluorene results in decreased expression of CCNG1 mRNA 2-Acetylaminofluorene results in increased expression of CCNG1 mRNA
|
CTD |
PMID:17070881 PMID:17317680 PMID:19167416 PMID:21607683 PMID:22584684 |
|
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
|
|
| G
|
Cd276
|
Cd276 molecule
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CD276 mRNA
|
CTD |
PMID:17070881 PMID:21784091 |
|
NCBI chr 8:67,833,587...67,863,918
Ensembl chr 8:67,829,048...67,864,505
|
|
| G
|
Cd44
|
CD44 molecule
|
increases expression
|
EXP IEP
|
2-Acetylaminofluorene results in increased expression of CD44 mRNA; 2-Acetylaminofluorene results in increased expression of CD44 protein 2-Fluorenylacetamide increases CD44 mRNA in liver, and protein in liver and serum
|
CTD RGD |
PMID:17187413 PMID:22584684 PMID:33211169 PMID:31966914 |
RGD:25823185 |
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cdc37
|
cell division cycle 37, HSP90 cochaperone
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 mRNA; [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDC37 protein
|
CTD |
PMID:16317707 |
|
NCBI chr 8:27,954,292...27,966,935
Ensembl chr 8:27,948,016...27,983,931
|
|
| G
|
Cdca3
|
cell division cycle associated 3
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CDCA3 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068
|
|
| G
|
Cdh13
|
cadherin 13
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CDH13 mRNA
|
CTD |
PMID:21784091 |
|
NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119
|
|
| G
|
Cdh22
|
cadherin 22
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CDH22 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:174,264,869...174,390,142
|
|
| G
|
Cdh3
|
cadherin 3
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CDH3 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CDK1 mRNA
|
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
multiple interactions decreases activity
|
EXP
|
2-Acetylaminofluorene inhibits the reaction [CDK2 protein binds to CCNE1 protein]; 2-Acetylaminofluorene results in decreased localization of and results in decreased phosphorylation of and results in decreased activity of CDK2 protein 2-Acetylaminofluorene results in decreased activity of CDK2 protein
|
CTD |
PMID:10708481 PMID:15158336 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
increases activity
|
EXP
|
2-Acetylaminofluorene results in increased activity of CDK4 protein
|
CTD |
PMID:15158336 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
EXP ISO
|
2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of CDKN1A protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA]; pioglitazone inhibits the reaction [2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]] 2-Acetylaminofluorene results in increased expression of CDKN1A mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CDKN1A mRNA] 2-Acetylaminofluorene results in increased expression of CDKN1A mRNA; 2-Acetylaminofluorene results in increased expression of CDKN1A protein
|
CTD |
PMID:10708481 PMID:11003613 PMID:14633663 PMID:17070881 PMID:17317680 PMID:17582756 PMID:19167416 PMID:21607683 PMID:22213190 PMID:22584684 More...
|
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
multiple interactions
|
EXP
|
2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]; Pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]]
|
CTD |
PMID:17582756 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
multiple interactions increases methylation increases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDKN2A mRNA; [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDKN2A protein 2-Acetylaminofluorene results in increased methylation of CDKN2A gene; 2-Acetylaminofluorene results in increased methylation of CDKN2A promoter 2-Acetylaminofluorene results in increased expression of CDKN2A mRNA
|
CTD |
PMID:16317707 PMID:18204080 PMID:19167416 PMID:20188851 PMID:22213190 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
| G
|
Cdkn2b
|
cyclin-dependent kinase inhibitor 2B
|
increases expression
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of CDKN2B mRNA
|
CTD |
PMID:17317680 PMID:22213190 |
|
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
|
|
| G
|
Cdkn2c
|
cyclin-dependent kinase inhibitor 2C
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CDKN2C mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891
|
|
| G
|
Cdkn3
|
cyclin-dependent kinase inhibitor 3
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CDKN3 mRNA
|
CTD |
PMID:22213190 PMID:22584684 |
|
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of CEBPA protein
|
CTD |
PMID:20188851 PMID:21785164 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
multiple interactions decreases expression
|
EXP
|
2-Acetylaminofluorene inhibits the reaction [CEBPB protein binds to HAMP promoter] 2-Acetylaminofluorene results in decreased expression of CEBPB protein
|
CTD |
PMID:21785164 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Ces2e
|
carboxylesterase 2E
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of CES2E mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr19:163,899...179,274
Ensembl chr19:163,859...179,308
|
|
| G
|
Ces3a
|
carboxylesterase 3a
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of CES3 mRNA
|
CTD |
PMID:20713471 |
|
NCBI chr19:49,902,312...49,910,484
|
|
| G
|
Ckmt1
|
creatine kinase, mitochondrial 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of CKMT1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 3:128,783,408...128,789,485
Ensembl chr 3:128,783,597...128,789,483
|
|
| G
|
Cldn4
|
claudin 4
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CLDN4 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958
|
|
| G
|
Cldn7
|
claudin 7
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CLDN7 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905
|
|
| G
|
Clu
|
clusterin
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CLU mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CLU mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cmas
|
cytidine monophosphate N-acetylneuraminic acid synthetase
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CMAS protein
|
CTD |
PMID:6331524 |
|
NCBI chr 4:177,449,801...177,468,117
Ensembl chr 4:177,449,732...177,476,291
|
|
| G
|
Col17a1
|
collagen type XVII alpha 1 chain
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of COL17A1 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 1:256,472,648...256,518,857
Ensembl chr 1:256,472,648...256,518,851
|
|
| G
|
Commd3
|
COMM domain containing 3
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of COMMD3 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610
|
|
| G
|
Coq6
|
coenzyme Q6 monooxygenase
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of COQ6 mRNA
|
CTD |
PMID:16158176 |
|
NCBI chr 6:109,738,934...109,750,315
Ensembl chr 6:109,738,951...109,750,310
|
|
| G
|
Cpq
|
carboxypeptidase Q
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of CPQ mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:66,149,377...66,716,137
|
|
| G
|
Cps1
|
carbamoyl-phosphate synthase 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Carbon Tetrachloride] affects the expression of CPS1 protein
|
CTD |
PMID:11813887 |
|
NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734
|
|
| G
|
Crebbp
|
CREB binding protein
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of CREBBP mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
|
|
| G
|
Cryab
|
crystallin, alpha B
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CRYAB mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
|
|
| G
|
Cryl1
|
crystallin, lambda 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CRYL1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CRYL1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr15:35,542,628...35,661,563
Ensembl chr15:35,542,628...35,661,563
|
|
| G
|
Csta
|
cystatin A
|
affects expression
|
ISO
|
2-Acetylaminofluorene affects the expression of CSTA mRNA
|
CTD |
PMID:27825931 |
|
NCBI chr11:78,125,813...78,136,818
Ensembl chr11:78,125,800...78,136,822
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CX3CL1 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
affects expression
|
EXP
|
2-Acetylaminofluorene affects the expression of CXCL1 protein
|
CTD |
PMID:25051504 |
|
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
affects expression
|
EXP
|
2-Acetylaminofluorene affects the expression of CXCL10 protein
|
CTD |
PMID:25051504 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
multiple interactions increases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Carbon Tetrachloride] results in increased expression of CXCL12 protein 2-Acetylaminofluorene results in increased expression of CXCL12 mRNA; 2-Acetylaminofluorene results in increased expression of CXCL12 protein
|
CTD |
PMID:12626097 PMID:15579440 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
affects expression
|
EXP
|
2-Acetylaminofluorene affects the expression of CXCL2 protein
|
CTD |
PMID:25051504 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
increases expression multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased expression of CXCR4 mRNA [2-Acetylaminofluorene co-treated with Carbon Tetrachloride] results in increased expression of CXCR4 protein
|
CTD |
PMID:12626097 PMID:15579440 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases hydrolysis increases expression multiple interactions
|
ISO EXP
|
CYP1A1 results in increased hydrolysis of 2-Acetylaminofluorene 2-Acetylaminofluorene results in increased expression of CYP1A1 mRNA 2-Acetylaminofluorene analog results in increased expression of CYP1A1 protein; 2-Acetylaminofluorene results in increased expression of CYP1A1 mRNA; 2-Acetylaminofluorene results in increased expression of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP1A1 mRNA]
|
CTD |
PMID:2334931 PMID:10445401 PMID:11888708 PMID:15916741 PMID:20713471 PMID:25224404 More...
|
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
affects metabolic processing increases activity increases hydrolysis multiple interactions decreases expression increases expression
|
ISO EXP
|
CYP1A2 protein affects the metabolism of 2-Acetylaminofluorene CYP1A2 protein results in increased activity of 2-Acetylaminofluorene CYP1A2 results in increased hydrolysis of 2-Acetylaminofluorene NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA] 2-Acetylaminofluorene analog results in decreased expression of CYP1A2 protein; 2-Acetylaminofluorene results in decreased expression of CYP1A2 protein 2-Acetylaminofluorene results in increased expression of CYP1A2 protein
|
CTD |
PMID:2334931 PMID:2655891 PMID:15450435 PMID:15916741 PMID:16381673 PMID:28245158 More...
|
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
increases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased expression of CYP1B1 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1B1 mRNA]
|
CTD |
PMID:17317680 PMID:20713471 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of CYP2A22 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730
|
|
| G
|
Cyp2b1
|
cytochrome P450, family 2, subfamily b, polypeptide 1
|
decreases expression increases expression
|
EXP
|
2-Acetylaminofluorene analog results in decreased expression of CYP2B1 protein; 2-Acetylaminofluorene results in decreased expression of CYP2B1 protein 2-Acetylaminofluorene results in increased expression of CYP2B1 protein
|
CTD |
PMID:10445401 PMID:15916741 |
|
NCBI chr 1:90,646,098...90,669,762
|
|
| G
|
Cyp2b2
|
cytochrome P450, family 2, subfamily b, polypeptide 2
|
decreases expression
|
EXP
|
2-Acetylaminofluorene analog results in decreased expression of CYP2B2 protein; 2-Acetylaminofluorene results in decreased expression of CYP2B2 protein
|
CTD |
PMID:15916741 |
|
NCBI chr 1:90,722,243...90,736,272
|
|
| G
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CYP2C13 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 1:248,706,787...248,787,239
Ensembl chr 1:248,706,788...248,787,210
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions increases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP2E1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CYP2E1 protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP2E1 protein] 2-Acetylaminofluorene analog results in increased expression of CYP2E1 protein; 2-Acetylaminofluorene results in increased expression of CYP2E1 protein
|
CTD |
PMID:14656948 PMID:15916741 PMID:16158176 PMID:17393424 PMID:23665045 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CYP3A2 protein
|
CTD |
PMID:10445401 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp3a23-3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
|
increases expression multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA; 2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 protein [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP3A23-3A1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP3A23-3A1 mRNA; NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA]; Trabectedin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA]
|
CTD |
PMID:12504080 PMID:14656948 PMID:16158176 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
|
|
| G
|
Cyp4f5
|
cytochrome P450, family 4, subfamily f, polypeptide 5
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of CYP4F5 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 7:12,194,567...12,209,495
Ensembl chr 7:12,195,022...12,209,965
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP7A1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Dap
|
death-associated protein
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of DAP mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of DAP mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 2:83,910,113...83,962,673
Ensembl chr 2:83,910,060...83,962,673
|
|
| G
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of DDAH1 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626
|
|
| G
|
Ddit4l
|
DNA-damage-inducible transcript 4-like
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of DDIT4L mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225
|
|
| G
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of DDR1 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276
|
|
| G
|
Des
|
desmin
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of DES mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347
|
|
| G
|
Dhodh
|
dihydroorotate dehydrogenase
|
decreases activity
|
EXP
|
2-Acetylaminofluorene results in decreased activity of DHODH protein
|
CTD |
PMID:6331524 |
|
NCBI chr19:54,460,636...54,483,049
Ensembl chr19:54,468,690...54,514,496
|
|
| G
|
Dlk1
|
delta like non-canonical Notch ligand 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of DLK1 mRNA; 2-Acetylaminofluorene results in increased expression of DLK1 protein
|
CTD |
PMID:15567716 PMID:17187413 PMID:17538966 |
|
NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529
|
|
| G
|
Dmp1
|
dentin matrix acidic phosphoprotein 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of DMP1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr14:5,833,111...5,867,154
Ensembl chr14:5,833,111...5,843,993
|
|
| G
|
E2f1
|
E2F transcription factor 1
|
decreases expression increases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of E2F1 protein 2-Acetylaminofluorene results in increased expression of E2F1 mRNA
|
CTD |
PMID:15158336 PMID:19167416 PMID:22213190 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
|
|
| G
|
E2f3
|
E2F transcription factor 3
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of E2F3 protein
|
CTD |
PMID:15158336 PMID:19167416 |
|
NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725
|
|
| G
|
E2f4
|
E2F transcription factor 4
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of E2F4 protein
|
CTD |
PMID:15158336 |
|
NCBI chr19:50,084,335...50,091,731
Ensembl chr19:50,084,335...50,091,834
|
|
| G
|
Eda2r
|
ectodysplasin A2 receptor
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of EDA2R mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr X:66,225,557...66,280,674
Ensembl chr X:66,236,111...66,280,663
|
|
| G
|
Egf
|
epidermal growth factor
|
decreases localization multiple interactions
|
EXP
|
2-Acetylaminofluorene results in decreased localization of EGF protein 2-Acetylaminofluorene affects the reaction [EGF protein results in increased phosphorylation of EGFR protein]
|
CTD |
PMID:10900465 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions decreases expression
|
EXP
|
2-Acetylaminofluorene affects the reaction [EGF protein results in increased phosphorylation of EGFR protein] 2-Acetylaminofluorene results in decreased expression of EGFR mRNA
|
CTD |
PMID:10900465 PMID:22213190 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egr1
|
early growth response 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of EGR1 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Ei24
|
EI24, autophagy associated transmembrane protein
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of EI24 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 8:44,683,138...44,699,502
Ensembl chr 8:44,683,144...44,695,214
|
|
| G
|
Emp2
|
epithelial membrane protein 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of EMP2 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532
|
|
| G
|
Enc1
|
ectodermal-neural cortex 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of ENC1 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721
|
|
| G
|
Eno1
|
enolase 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of ENO1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of ENO1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003 Ensembl chr 5:77,946,261...77,986,003
|
|
| G
|
Epcam
|
epithelial cell adhesion molecule
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of EPCAM mRNA
|
CTD |
PMID:17070881 PMID:17187413 |
|
NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702
|
|
| G
|
Epha1
|
Eph receptor A1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of EPHA1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474
|
|
| G
|
Ephx1
|
epoxide hydrolase 1
|
increases expression
|
EXP ISO
|
2-Acetylaminofluorene results in increased expression of EPHX1 mRNA
|
CTD |
PMID:17070881 PMID:17317680 PMID:21607683 |
|
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ERBB2 protein
|
CTD |
PMID:11350689 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Esr1
|
estrogen receptor 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of ESR1 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Exoc4
|
exocyst complex component 4
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of EXOC4 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943
|
|
| G
|
Fam110a
|
family with sequence similarity 110, member A
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of FAM110A mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 3:160,934,815...160,945,405
Ensembl chr 3:160,931,777...160,949,897
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of FAS mRNA
|
CTD |
PMID:17070881 PMID:22584684 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fbxw9
|
F-box and WD repeat domain containing 9
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of FBXW9 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr19:39,995,408...40,002,312
Ensembl chr19:39,995,408...40,002,312
|
|
| G
|
Fhit
|
fragile histidine triad diadenosine triphosphatase
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of FHIT mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr15:16,365,401...17,872,901
Ensembl chr15:16,747,338...17,872,621
|
|
| G
|
Flt3
|
Fms related receptor tyrosine kinase 3
|
affects expression
|
EXP
|
2-Acetylaminofluorene affects the expression of FLT3 mRNA
|
CTD |
PMID:18031378 |
|
NCBI chr12:12,660,035...12,735,584
Ensembl chr12:12,659,946...12,735,581
|
|
| G
|
Fn1
|
fibronectin 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of FN1 mRNA
|
CTD |
PMID:15940639 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of FOS protein; Drugs, Chinese Herbal inhibits the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of FOS protein]
|
CTD |
PMID:17696247 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fth1
|
ferritin heavy chain 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of FTH1 protein
|
CTD |
PMID:21785164 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
|
|
| G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of G6PC1 protein; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of G6PC1 protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of G6PC1 protein]
|
CTD |
PMID:15554553 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
|
|
| G
|
Gaa
|
alpha glucosidase
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of GAA mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr10:105,028,106...105,045,365
Ensembl chr10:105,028,307...105,045,366
|
|
| G
|
Gas2l3
|
growth arrest-specific 2 like 3
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of GAS2L3 mRNA
|
CTD |
PMID:20713471 |
|
NCBI chr 7:25,690,929...25,726,806
Ensembl chr 7:25,693,660...25,716,942
|
|
| G
|
Gcgr
|
glucagon receptor
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCGR mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GCGR mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
increases expression multiple interactions
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of GCLC mRNA [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLC mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GCLC mRNA
|
CTD |
PMID:14656948 PMID:16158176 PMID:16426233 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLM mRNA
|
CTD |
PMID:16158176 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of GDF15 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Ggt1
|
gamma-glutamyltransferase 1
|
increases expression multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased expression of GGT1 mRNA [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GGT1 protein; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GGT1 protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GGT1 protein]
|
CTD |
PMID:15554553 PMID:17187413 |
|
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of GJA1 mRNA; 2-Acetylaminofluorene results in increased expression of GJA1 protein
|
CTD |
PMID:15133858 PMID:17187413 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gjb1
|
gap junction protein, beta 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of GJB1 mRNA
|
CTD |
PMID:2559087 |
|
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843
|
|
| G
|
Gjb2
|
gap junction protein, beta 2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of GJB2 mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877
|
|
| G
|
Glrx3
|
glutaredoxin 3
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of GLRX3 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:201,671,481...201,701,717
|
|
| G
|
Gpc3
|
glypican 3
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of GPC3 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr X:136,789,770...137,157,598
Ensembl chr X:136,789,770...137,157,639
|
|
| G
|
Gpx2
|
glutathione peroxidase 2
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GPX2 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
|
|
| G
|
Gria3
|
glutamate ionotropic receptor AMPA type subunit 3
|
increases expression
|
EXP ISO
|
2-Acetylaminofluorene results in increased expression of GRIA3 mRNA
|
CTD |
PMID:17070881 PMID:21607683 |
|
NCBI chr X:125,103,975...125,369,690
Ensembl chr X:125,103,782...125,369,679
|
|
| G
|
Grina
|
glutamate ionotropic receptor NMDA type subunit associated protein 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of GRINA mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions decreases activity decreases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSR mRNA; Diosmin inhibits the reaction [2-Acetylaminofluorene results in decreased expression of GSR protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in decreased activity of GSR protein]
|
CTD |
PMID:16158176 PMID:23665045 PMID:26364502 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gss
|
glutathione synthetase
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of GSS mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306
|
|
| G
|
Gsta2
|
glutathione S-transferase alpha 2
|
multiple interactions increases expression
|
EXP ISO
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSTA2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTA2 mRNA 2-Acetylaminofluorene results in increased expression of GSTA1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 PMID:17317680 |
|
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of GSTM1 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
multiple interactions increases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein; Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein]; herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]; herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]; Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]; Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein] 2-Acetylaminofluorene results in increased expression of GSTP1 mRNA; 2-Acetylaminofluorene results in increased expression of GSTP1 protein
|
CTD |
PMID:12497209 PMID:12781041 PMID:12907702 PMID:15554553 PMID:17393424 PMID:18271918 PMID:21785164 PMID:22213190 More...
|
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gtse1
|
G-2 and S-phase expressed 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of GTSE1 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:118,829,903...118,846,661
|
|
| G
|
H2ax
|
H2A.X variant histone
|
increases expression increases phosphorylation
|
EXP ISO
|
2-Acetylaminofluorene results in increased expression of H2AX protein 2-Acetylaminofluorene results in increased phosphorylation of H2AX protein
|
CTD |
PMID:26338220 PMID:34510228 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hadha
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of HADHA mRNA
|
CTD |
PMID:16158176 |
|
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
|
|
| G
|
Hamp
|
hepcidin antimicrobial peptide
|
multiple interactions decreases expression
|
EXP
|
2-Acetylaminofluorene inhibits the reaction [CEBPB protein binds to HAMP promoter] 2-Acetylaminofluorene results in decreased expression of HAMP mRNA
|
CTD |
PMID:21785164 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
| G
|
Hebp2
|
heme binding protein 2
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of HEBP2 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 1:15,014,729...15,021,523
Ensembl chr 1:15,014,729...15,021,523
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of HMGCR mRNA; beta-ionone promotes the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of HMGCR mRNA]
|
CTD |
PMID:20435455 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of HMOX1 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hras
|
HRas proto-oncogene, GTPase
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of HRAS protein
|
CTD |
PMID:11350689 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
|
|
| G
|
Hsd17b6
|
hydroxysteroid (17-beta) dehydrogenase 6
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of HSD17B6 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 7:831,407...850,950
Ensembl chr 7:831,421...850,873
|
|
| G
|
Ica1
|
islet cell autoantigen 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ICA1 mRNA
|
CTD |
PMID:21784091 |
|
NCBI chr 4:37,622,759...37,771,055
Ensembl chr 4:37,622,759...37,770,569
|
|
| G
|
Id1
|
inhibitor of DNA binding 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of ID1 mRNA
|
CTD |
PMID:15120964 |
|
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
|
|
| G
|
Ifna1
|
interferon, alpha 1
|
multiple interactions
|
EXP
|
IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA]; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCND1 mRNA]; IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of CCNE1 mRNA]
|
CTD |
PMID:14633663 |
|
NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:108,143,240...108,143,809
|
|
| G
|
Ifna2
|
interferon alpha 2
|
multiple interactions
|
EXP
|
IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BAX protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of TP53 protein]; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TGFB1 protein]; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD2 protein]; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:11915028 PMID:15368444 |
|
NCBI chr 5:108,374,363...108,374,941
Ensembl chr 5:108,374,363...108,374,941
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions
|
EXP
|
2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein]
|
CTD |
PMID:14736494 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igf2
|
insulin-like growth factor 2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of IGF2 mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667
|
|
| G
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of IGFALS mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr10:14,397,076...14,408,439
Ensembl chr10:14,403,399...14,407,138
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
increases activity
|
ISO
|
2-Acetylaminofluorene results in increased activity of IKBKB protein
|
CTD |
PMID:11960367 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Il10
|
interleukin 10
|
affects expression
|
EXP
|
2-Acetylaminofluorene affects the expression of IL10 protein
|
CTD |
PMID:25051504 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il12b
|
interleukin 12B
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of IL12B protein
|
CTD |
PMID:25051504 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions increases expression affects expression
|
ISO EXP
|
2-Acetylaminofluorene inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] 2-Acetylaminofluorene results in increased expression of IL1B protein 2-Acetylaminofluorene affects the expression of IL1B mRNA
|
CTD |
PMID:14670622 PMID:25051504 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il2ra
|
interleukin 2 receptor subunit alpha
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of IL2RA mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507
|
|
| G
|
Il33
|
interleukin 33
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of IL33 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
|
|
| G
|
Il5
|
interleukin 5
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of IL5 protein
|
CTD |
PMID:25051504 |
|
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
|
|
| G
|
Il6
|
interleukin 6
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of IL6 protein
|
CTD |
PMID:25051504 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Itgb4
|
integrin subunit beta 4
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of ITGB4 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of JUN protein; Drugs, Chinese Herbal inhibits the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of JUN protein]
|
CTD |
PMID:17696247 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Kdm6a
|
lysine demethylase 6A
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of KDM6A mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr X:6,920,374...7,060,027
Ensembl chr X:6,920,343...7,059,960
|
|
| G
|
Kif11
|
kinesin family member 11
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of KIF11 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250
|
|
| G
|
Kit
|
KIT proto-oncogene receptor tyrosine kinase
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of KIT protein
|
CTD |
PMID:15133858 |
|
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
|
|
| G
|
Krt14
|
keratin 14
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of KRT14 protein
|
CTD |
PMID:33211169 |
|
NCBI chr10:85,638,182...85,642,450
|
|
| G
|
Krt15
|
keratin 15
|
increases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased expression of KRT15 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT15 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr10:85,567,197...85,571,014
Ensembl chr10:85,567,202...85,571,142
|
|
| G
|
Krt19
|
keratin 19
|
increases expression multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased expression of KRT19 mRNA; 2-Acetylaminofluorene results in increased expression of KRT19 protein [Carbon Tetrachloride co-treated with 2-Acetylaminofluorene] results in increased expression of KRT19 protein
|
CTD |
PMID:15133858 PMID:17187413 PMID:17661067 |
|
NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952
|
|
| G
|
Krt20
|
keratin 20
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of KRT20 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr10:84,880,952...84,890,285
Ensembl chr10:84,880,952...84,890,285
|
|
| G
|
Krt23
|
keratin 23
|
multiple interactions increases expression
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT23 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr10:84,930,603...84,946,929
Ensembl chr10:84,930,603...84,946,929
|
|
| G
|
Krt4
|
keratin 4
|
increases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased expression of KRT4 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT4 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 7:134,924,753...134,931,050
Ensembl chr 7:134,924,753...134,930,713
|
|
| G
|
Krt8
|
keratin 8
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of KRT8 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of KRT8 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403
|
|
| G
|
Lep
|
leptin
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of LEP protein
|
CTD |
PMID:25051504 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lig4
|
DNA ligase 4
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of LIG4 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr16:86,220,345...86,228,930
Ensembl chr16:86,220,279...86,229,926
|
|
| G
|
Ly6d
|
lymphocyte antigen 6 family member D
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of LY6D mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 7:108,532,207...108,533,943
Ensembl chr 7:108,532,215...108,533,716
|
|
| G
|
Ly6e
|
lymphocyte antigen 6 family member E
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of LY6E mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443
|
|
| G
|
Lypd3
|
Ly6/Plaur domain containing 3
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of LYPD3 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 1:89,354,354...89,358,806
Ensembl chr 1:89,354,335...89,358,810
|
|
| G
|
Lzic
|
leucine zipper and CTNNBIP1 domain containing
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of LZIC mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 5:165,211,359...165,224,569
Ensembl chr 5:165,211,302...165,224,568
|
|
| G
|
Mal
|
mal, T-cell differentiation protein
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of MAL mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 3:135,317,664...135,341,423
Ensembl chr 3:135,317,664...135,341,423
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
EXP
|
2-Acetylaminofluorene affects the phosphorylation of and affects the activity of MAPK8 protein
|
CTD |
PMID:17546627 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mat1a
|
methionine adenosyltransferase 1A
|
affects acetylation affects methylation decreases expression
|
EXP
|
2-Acetylaminofluorene affects the acetylation of MAT1A exon; 2-Acetylaminofluorene affects the acetylation of MAT1A promoter 2-Acetylaminofluorene affects the methylation of MAT1A exon; 2-Acetylaminofluorene affects the methylation of MAT1A promoter 2-Acetylaminofluorene results in decreased expression of MAT1A mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr16:17,017,168...17,035,368
Ensembl chr16:17,016,030...17,035,367
|
|
| G
|
Matn2
|
matrilin 2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MATN2 mRNA; 2-Acetylaminofluorene results in increased expression of MATN2 protein
|
CTD |
PMID:17513098 |
|
NCBI chr 7:67,380,140...67,529,767
Ensembl chr 7:67,380,168...67,530,153
|
|
| G
|
Mbl2
|
mannose binding lectin 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of MBL2 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
multiple interactions increases expression
|
EXP ISO
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of MDM2 protein 2-Acetylaminofluorene results in increased expression of MDM2 mRNA; 2-Acetylaminofluorene results in increased expression of MDM2 protein
|
CTD |
PMID:11003613 PMID:19167416 PMID:21607683 PMID:22213190 PMID:22584684 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Meg3
|
maternally expressed 3
|
decreases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in decreased expression of MEG3 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of MEG3 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 6:134,274,056...134,306,249
|
|
| G
|
Mgmt
|
O-6-methylguanine-DNA methyltransferase
|
increases expression decreases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MGMT mRNA 2-Acetylaminofluorene results in decreased expression of MGMT mRNA
|
CTD |
PMID:17070881 PMID:22213190 |
|
NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482
|
|
| G
|
Mgst2
|
microsomal glutathione S-transferase 2
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of MGST2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MGST2 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661
|
|
| G
|
Mir106b
|
microRNA 106b
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR106B mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr12:22,157,053...22,157,134
|
|
| G
|
Mir125b1
|
microRNA 125b-1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MIR125B-1 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 8:50,850,036...50,850,122
Ensembl chr 8:50,850,036...50,850,122
|
|
| G
|
Mir130b
|
microRNA 130b
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR130B mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr11:97,384,380...97,384,461
Ensembl chr11:97,384,380...97,384,461
|
|
| G
|
Mir132
|
microRNA 132
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR132 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr10:60,522,033...60,522,133
Ensembl chr10:60,522,033...60,522,133
|
|
| G
|
Mir146b
|
microRNA 146b
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR146B mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:255,144,860...255,144,947
|
|
| G
|
Mir155
|
microRNA 155
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR155 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir17
|
microRNA 17
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR17; 2-Acetylaminofluorene results in increased expression of MIR17 mRNA
|
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr15:98,587,848...98,587,931
Ensembl chr15:98,587,848...98,587,931
|
|
| G
|
Mir181a-1
|
microRNA 181a-1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR181A-1 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr13:52,037,067...52,037,166
|
|
| G
|
Mir181b2
|
microRNA 181b-2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR181B-2 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 3:43,026,666...43,026,753
Ensembl chr 3:43,026,666...43,026,753
|
|
| G
|
Mir181c
|
microRNA 181c
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MIR181C mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr19:40,888,291...40,888,396
Ensembl chr19:40,888,291...40,888,396
|
|
| G
|
Mir182
|
microRNA 182
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR182 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 4:59,752,246...59,752,307
|
|
| G
|
Mir185
|
microRNA 185
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR185 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr11:96,169,028...96,169,107
Ensembl chr11:96,169,028...96,169,107
|
|
| G
|
Mir18a
|
microRNA 18a
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR18A; 2-Acetylaminofluorene results in increased expression of MIR18A mRNA
|
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr15:98,587,984...98,588,079
Ensembl chr15:98,587,984...98,588,079
|
|
| G
|
Mir200a
|
microRNA 200a
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR200A mRNA
|
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr 5:171,930,717...171,930,805
|
|
| G
|
Mir200b
|
microRNA 200b
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR200B mRNA
|
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr 5:171,931,495...171,931,589
|
|
| G
|
Mir200c
|
microRNA 200c
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR200C mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 4:159,209,965...159,210,033
|
|
| G
|
Mir202
|
microRNA 202
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MIR202 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 1:204,184,345...204,184,416
|
|
| G
|
Mir203
|
microRNA 203
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MIR203 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 6:137,020,691...137,020,805
|
|
| G
|
Mir204
|
microRNA 204
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MIR204 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 1:229,743,461...229,743,570
Ensembl chr 1:229,743,461...229,743,570
|
|
| G
|
Mir205
|
microRNA 205
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR205 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr13:107,564,535...107,564,642
|
|
| G
|
Mir20a
|
microRNA 20a
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR20A; 2-Acetylaminofluorene results in increased expression of MIR20A mRNA
|
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr15:98,588,303...98,588,387
Ensembl chr15:98,588,303...98,588,387
|
|
| G
|
Mir21
|
microRNA 21
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR21 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mir214
|
microRNA 214
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR214 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr13:77,121,645...77,121,752
Ensembl chr13:77,121,643...77,121,752
|
|
| G
|
Mir22
|
microRNA 22
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR22 mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr10:60,805,331...60,805,425
Ensembl chr10:60,805,331...60,805,425
|
|
| G
|
Mir221
|
microRNA 221
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR221 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr X:6,023,182...6,023,290
Ensembl chr X:6,023,182...6,023,290
|
|
| G
|
Mir293
|
microRNA 293
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR293 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 1:74,878,457...74,878,528
|
|
| G
|
Mir31
|
microRNA 31
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR31; 2-Acetylaminofluorene results in increased expression of MIR31 mRNA
|
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr 5:108,714,849...108,714,954
|
|
| G
|
Mir34a
|
microRNA 34a
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR34A mRNA
|
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053
|
|
| G
|
Mir382
|
microRNA 382
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR382 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 6:134,569,944...134,570,023
|
|
| G
|
Mir410
|
microRNA 410
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MIR410 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 6:134,579,763...134,579,838
Ensembl chr 6:134,579,759...134,579,839
|
|
| G
|
Mir429
|
microRNA 429
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR429 mRNA
|
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr 5:171,929,682...171,929,766
|
|
| G
|
Mir490
|
microRNA 490
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MIR490 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 4:66,014,586...66,014,669
Ensembl chr 4:66,014,586...66,014,669
|
|
| G
|
Mir93
|
microRNA 93
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR93; 2-Acetylaminofluorene results in increased expression of MIR93 mRNA
|
CTD |
PMID:19167416 PMID:20188851 |
|
NCBI chr12:22,156,844...22,156,930
|
|
| G
|
Mir96
|
microRNA 96
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIR96 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 4:59,755,841...59,755,946
|
|
| G
|
Mir99a
|
microRNA 99a
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MIR99A mRNA
|
CTD |
PMID:19167416 PMID:22584684 |
|
NCBI chr11:29,687,392...29,687,472
Ensembl chr11:29,687,392...29,687,472
|
|
| G
|
Mirlet7b
|
microRNA let-7b
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIRLET7B mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 7:118,684,038...118,684,122
Ensembl chr 7:118,684,038...118,684,122
|
|
| G
|
Mirlet7c-1
|
microRNA let-7c
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIRLET7C-1 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr11:29,688,112...29,688,205
Ensembl chr11:29,688,107...29,688,214
|
|
| G
|
Mirlet7i
|
microRNA let-7i
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MIRLET7I mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 7:60,527,877...60,527,961
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
multiple interactions increases expression
|
EXP ISO
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]; Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein] 2-Acetylaminofluorene results in increased expression of MKI67 mRNA
|
CTD |
PMID:15565650 PMID:17317680 PMID:17393424 PMID:23665045 PMID:26338220 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MMP2 mRNA
|
CTD |
PMID:18678246 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MMP9 mRNA
|
CTD |
PMID:18678246 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mt1a
|
metallothionein 1A
|
multiple interactions increases expression
|
EXP
|
Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MT1A protein]
|
CTD |
PMID:15565650 |
|
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
decreases expression decreases methylation
|
EXP
|
2-Acetylaminofluorene results in decreased expression of MTHFR mRNA 2-Acetylaminofluorene results in decreased methylation of MTHFR promoter
|
CTD |
PMID:22213190 |
|
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of MUC1 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
| G
|
Mybl1
|
MYB proto-oncogene like 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of MYBL1 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
multiple interactions increases expression increases mutagenesis
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of MYC protein; Drugs, Chinese Herbal inhibits the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of MYC protein] 2-Acetylaminofluorene results in increased expression of MYC protein 2-Acetylaminofluorene results in increased mutagenesis of MYC gene
|
CTD |
PMID:11350689 PMID:17696247 PMID:19167416 PMID:20188851 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of NAMPT mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
| G
|
Nat1
|
N-acetyltransferase 1
|
increases activity
|
ISO
|
NAT1 protein results in increased activity of 2-Acetylaminofluorene
|
CTD |
PMID:15450435 |
|
NCBI chr16:26,984,882...27,005,194
Ensembl chr16:26,982,625...26,986,527
|
|
| G
|
Nat2
|
N-acetyltransferase 2
|
increases activity
|
ISO
|
NAT2 protein results in increased activity of 2-Acetylaminofluorene
|
CTD |
PMID:15450435 |
|
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
|
|
| G
|
Nek6
|
NIMA-related kinase 6
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of NEK6 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 3:42,693,994...42,766,026
Ensembl chr 3:42,693,971...42,767,773
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases expression increases activity
|
ISO
|
2-Acetylaminofluorene results in increased expression of NFE2L2 mRNA 2-Acetylaminofluorene results in increased activity of NFE2L2 protein
|
CTD |
PMID:21607683 PMID:30114225 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions increases localization
|
ISO
|
[RELA protein binds to NFKB1 protein] affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA] 2-Acetylaminofluorene results in increased localization of NFKB1 protein Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased localization of NFKB1 protein]
|
CTD |
PMID:11960367 PMID:17303067 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein; Acetylcysteine inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein]; S-Adenosylmethionine inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein]
|
CTD |
PMID:18404532 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nfkbib
|
NFKB inhibitor beta
|
multiple interactions increases degradation
|
EXP
|
[2-Acetylaminofluorene results in increased abundance of Reactive Oxygen Species] which results in increased degradation of NFKBIB protein 2-Acetylaminofluorene results in increased degradation of NFKBIB protein
|
CTD |
PMID:11020383 |
|
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:93,173,820...93,326,366
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of TNFRSF10B mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Ninj1
|
ninjurin 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of NINJ1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NINJ1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr17:15,659,208...15,668,115
Ensembl chr17:15,659,200...15,668,063
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions increases expression
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NOS2 protein; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of NOS2 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of NOS2 protein]
|
CTD |
PMID:23665045 PMID:26364502 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
increases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased expression of NOS3 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of NOS3 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Notch1
|
notch receptor 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of NOTCH1 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613
|
|
| G
|
Nprl2
|
NPR2-like, GATOR1 complex subunit
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of NPRL2 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 8:117,094,443...117,097,639
Ensembl chr 8:117,094,441...117,097,637
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases expression
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of NQO1 mRNA
|
CTD |
PMID:21607683 PMID:22213190 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases expression multiple interactions
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of NR1I2 mRNA NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA] NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCC2 mRNA]; NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCG2 mRNA]; NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA]; NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP3A11 mRNA]
|
CTD |
PMID:12504080 PMID:16381673 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nudcd2
|
NudC domain containing 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of NUDCD2 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr10:25,665,493...25,671,010
Ensembl chr10:25,665,509...25,682,902
|
|
| G
|
Nudt7
|
nudix hydrolase 7
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of NUDT7 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr19:59,034,808...59,049,148
Ensembl chr19:59,034,839...59,063,994
|
|
| G
|
Nup50-ps1
|
nucleoporin 50, pseudogene 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of SPG7 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of SPG7 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 4:130,344,273...130,346,002
Ensembl chr 4:130,342,422...130,346,296
|
|
| G
|
Nupr1
|
nuclear protein 1, transcriptional regulator
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of NUPR1 mRNA
|
CTD |
PMID:17070881 PMID:22584684 |
|
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
|
|
| G
|
Nusap1
|
nucleolar and spindle associated protein 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of NUSAP1 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237
|
|
| G
|
Ociad2
|
OCIA domain containing 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of OCIAD2 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr14:35,225,291...35,243,306
Ensembl chr14:35,225,255...35,243,311
|
|
| G
|
Olfm1
|
olfactomedin 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of OLFM1 mRNA
|
CTD |
PMID:20713471 |
|
NCBI chr 3:31,918,512...31,956,261
Ensembl chr 3:31,918,573...31,956,260
|
|
| G
|
Or2at1
|
olfactory receptor family 2 subfamily AT member 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of OR2AT1 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 1:163,501,335...163,502,300
Ensembl chr 1:163,501,335...163,502,300
|
|
| G
|
Osm
|
oncostatin M
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of OSM mRNA
|
CTD |
PMID:15743783 PMID:18678246 |
|
NCBI chr14:83,327,202...83,332,073
Ensembl chr14:83,327,554...83,331,827
|
|
| G
|
Osmr
|
oncostatin M receptor
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of OSMR mRNA
|
CTD |
PMID:15743783 |
|
NCBI chr 2:57,634,517...57,688,802
Ensembl chr 2:57,634,517...57,688,561
|
|
| G
|
Padi2
|
peptidyl arginine deiminase 2
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of PADI2 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 5:158,492,087...158,534,662
Ensembl chr 5:158,492,066...158,534,662
|
|
| G
|
Pbsn
|
probasin
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of PBSN mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr X:45,792,738...45,807,983
Ensembl chr X:45,792,738...45,807,983
|
|
| G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of PCK1 mRNA
|
CTD |
PMID:16510358 |
|
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions increases expression
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PCNA protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PCNA protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]; Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of PCNA protein]
|
CTD |
PMID:16352317 PMID:17393424 PMID:19167416 PMID:23665045 PMID:26364502 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pdia3
|
protein disulfide isomerase family A, member 3
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of PDIA3 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PDIA3 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of PECAM1 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Perp
|
p53 apoptosis effector related to PMP22
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PERP mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:15,361,778...15,374,687
|
|
| G
|
Phlda3
|
pleckstrin homology-like domain, family A, member 3
|
increases expression
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of PHLDA3 mRNA
|
CTD |
PMID:17070881 PMID:21607683 PMID:22584684 |
|
NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621
|
|
| G
|
Phyh
|
phytanoyl-CoA 2-hydroxylase
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of PHYH mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of PHYH mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr17:78,238,747...78,255,645
Ensembl chr17:78,238,747...78,255,645
|
|
| G
|
Piga
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
increases mutagenesis
|
EXP
|
2-Acetylaminofluorene results in increased mutagenesis of PIGA
|
CTD |
PMID:22923490 |
|
NCBI chr X:33,672,832...33,687,747
Ensembl chr X:33,674,923...33,687,636
|
|
| G
|
Pkd1
|
polycystin 1, transient receptor potential channel interacting
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of PKD1 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:14,078,679...14,125,681
|
|
| G
|
Pkm
|
pyruvate kinase M1/2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of PKM mRNA; 2-Acetylaminofluorene results in increased expression of PKM protein
|
CTD |
PMID:17538966 |
|
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396
|
|
| G
|
Pkp1
|
plakophilin 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of PKP1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr13:49,861,340...49,909,162
Ensembl chr13:49,861,340...49,909,162
|
|
| G
|
Plk2
|
polo-like kinase 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of PLK2 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
|
|
| G
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
increases expression multiple interactions
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of PMAIP1 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PMAIP1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of PMAIP1 mRNA]
|
CTD |
PMID:17317680 PMID:19167416 |
|
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
|
|
| G
|
Polk
|
DNA polymerase kappa
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of POLK mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 2:29,556,831...29,616,960
Ensembl chr 2:29,557,336...29,616,960
|
|
| G
|
Por
|
cytochrome p450 oxidoreductase
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of POR mRNA
|
CTD |
PMID:15089088 |
|
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
|
|
| G
|
Prc1
|
protein regulator of cytokinesis 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of PRC1 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012
|
|
| G
|
Prkch
|
protein kinase C, eta
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of PRKCH mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PRKCH mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:98,027,646...98,226,477
|
|
| G
|
Prom1
|
prominin 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of PROM1 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr14:71,202,303...71,307,008
Ensembl chr14:71,202,336...71,307,002
|
|
| G
|
Prox1
|
prospero homeobox 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of PROX1 mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr13:104,196,615...104,251,007
Ensembl chr13:104,200,378...104,250,975
|
|
| G
|
Psmd10
|
proteasome 26S subunit, non-ATPase 10
|
increases expression multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased expression of PSMD10 protein RB1 protein affects the reaction [2-Acetylaminofluorene results in increased expression of PSMD10 protein]
|
CTD |
PMID:16448463 |
|
NCBI chr X:109,445,291...109,453,605
Ensembl chr X:109,445,291...109,453,605
|
|
| G
|
Psrc1
|
proline and serine rich coiled-coil 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of PSRC1 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:198,705,839...198,714,997
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of PTEN protein
|
CTD |
PMID:19167416 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Ptgr1
|
prostaglandin reductase 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of PTGR1 mRNA
|
CTD |
PMID:16158176 |
|
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions increases expression
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PTGS2 protein; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of PTGS2 protein]; geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of PTGS2 protein]
|
CTD |
PMID:23665045 PMID:26364502 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptn
|
pleiotrophin
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of PTN mRNA
|
CTD |
PMID:12057922 |
|
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482
|
|
| G
|
Ptp4a3
|
protein tyrosine phosphatase 4A3
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of PTP4A3 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 7:107,518,220...107,549,949
Ensembl chr 7:107,541,047...107,549,949
|
|
| G
|
Ptprc
|
protein tyrosine phosphatase, receptor type, C
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of PTPRC mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746
|
|
| G
|
Pttg1
|
PTTG1 regulator of sister chromatid separation, securin
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of PTTG1 mRNA
|
CTD |
PMID:19167416 |
|
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309
|
|
| G
|
Pvt1
|
Pvt1 oncogene
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of PVT1 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 7:95,545,916...95,769,306
|
|
| G
|
Rac1
|
Rac family small GTPase 1
|
increases activity multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased activity of RAC1 protein [2-Acetylaminofluorene results in increased activity of RAC1 protein] which results in increased expression of ABCB1 mRNA
|
CTD |
PMID:11960367 |
|
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109
|
|
| G
|
Rassf1
|
Ras association domain family member 1
|
increases methylation
|
EXP
|
2-Acetylaminofluorene results in increased methylation of RASSF1 promoter
|
CTD |
PMID:20188851 |
|
NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:117,103,362...117,114,805
|
|
| G
|
Rb1
|
RB transcriptional corepressor 1
|
affects phosphorylation multiple interactions
|
EXP
|
2-Acetylaminofluorene affects the phosphorylation of RB1 protein 2-Acetylaminofluorene results in increased expression of and results in increased phosphorylation of RB1 protein; RB1 protein affects the reaction [2-Acetylaminofluorene results in increased expression of PSMD10 protein]
|
CTD |
PMID:15158336 PMID:16448463 |
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
|
|
| G
|
Rbx1
|
ring-box 1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of RBX1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:114,870,972...114,881,191
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases activity increases expression multiple interactions increases localization
|
ISO EXP
|
2-Acetylaminofluorene results in increased activity of RELA protein 2-Acetylaminofluorene results in increased expression of RELA protein geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of RELA protein]; RELA protein affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1B mRNA] 2-Acetylaminofluorene results in increased localization of RELA protein [RELA protein binds to NFKB1 protein] affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA] 2-Acetylaminofluorene inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein]; Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased localization of RELA protein]
|
CTD |
PMID:11020383 PMID:11960367 PMID:14670622 PMID:17303067 PMID:26364502 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Rgn
|
regucalcin
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of RGN mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of RGN mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr X:4,172,537...4,190,112
Ensembl chr X:4,172,537...4,190,251
|
|
| G
|
Rgs2
|
regulator of G-protein signaling 2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of RGS2 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697
|
|
| G
|
Rhbdf2
|
rhomboid 5 homolog 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of RHBDF2 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr10:102,331,991...102,359,117
Ensembl chr10:102,331,991...102,359,117
|
|
| G
|
Rhob
|
ras homolog family member B
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of RHOB mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772
|
|
| G
|
Rhobtb2
|
Rho-related BTB domain containing 2
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of RHOBTB2 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr15:51,278,024...51,298,209
Ensembl chr15:51,280,149...51,298,209
|
|
| G
|
Ripk1
|
receptor interacting serine/threonine kinase 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of RIPK1 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167
|
|
| G
|
Ripk3
|
receptor-interacting serine-threonine kinase 3
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of RIPK3 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr15:33,253,071...33,262,025
Ensembl chr15:33,253,071...33,262,025
|
|
| G
|
Ripk4
|
receptor-interacting serine-threonine kinase 4
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of RIPK4 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr11:50,591,926...50,614,169
Ensembl chr11:50,591,936...50,614,169
|
|
| G
|
Ros1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ROS1 mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr20:31,975,328...32,126,675
Ensembl chr20:31,975,329...32,126,547
|
|
| G
|
Rplp0
|
ribosomal protein lateral stalk subunit P0
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of RPLP0 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of RPLP0 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr12:46,715,121...46,718,390
Ensembl chr12:46,715,124...46,718,422
|
|
| G
|
Rprm
|
reprimo, TP53 dependent G2 arrest mediator homolog
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of RPRM mRNA] 2-Acetylaminofluorene results in increased expression of RPRM mRNA 2-Acetylaminofluorene results in decreased expression of RPRM mRNA
|
CTD |
PMID:17317680 PMID:19167416 PMID:22584684 |
|
NCBI chr 3:58,948,618...58,950,035
Ensembl chr 3:58,799,866...58,950,542
|
|
| G
|
Rps27l
|
ribosomal protein S27-like
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of RPS27L mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130 Ensembl chr 8:33,713,661...33,714,130
|
|
| G
|
Rrm1
|
ribonucleotide reductase catalytic subunit M1
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of RRM1 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:166,235,900...166,260,944
|
|
| G
|
Rrm2b
|
ribonucleotide reductase regulatory TP53 inducible subunit M2B
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of RRM2B mRNA
|
CTD |
PMID:21704725 |
|
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:70,965,590...70,993,670
|
|
| G
|
Rsad2
|
radical S-adenosyl methionine domain containing 2
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of RSAD2 mRNA
|
CTD |
PMID:20713471 |
|
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320
|
|
| G
|
S100a11
|
S100 calcium binding protein A11
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of S100A11 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541
|
|
| G
|
S100a14
|
S100 calcium binding protein A14
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of S100A14 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 2:178,305,976...178,308,004
Ensembl chr 2:178,306,025...178,307,999
|
|
| G
|
Scarb2
|
scavenger receptor class B, member 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of SCARB2 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr14:15,842,583...15,894,123
Ensembl chr14:15,842,515...15,896,671
|
|
| G
|
Scpep1
|
serine carboxypeptidase 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of SCPEP1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of SCPEP1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr10:74,200,491...74,230,107
Ensembl chr10:74,200,491...74,230,241
|
|
| G
|
Sctr
|
secretin receptor
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SCTR mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr13:33,680,562...33,744,049
Ensembl chr13:33,680,627...33,733,709
|
|
| G
|
Serpina7
|
serpin family A member 7
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SERPINA7 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr X:107,452,044...107,510,958
Ensembl chr X:107,452,044...107,457,681
|
|
| G
|
Serpinb5
|
serpin family B member 5
|
increases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased expression of SERPINB5 mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of SERPINB5 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr13:23,500,203...23,520,401
Ensembl chr13:23,500,198...23,520,400
|
|
| G
|
Serpinf1
|
serpin family F member 1
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of SERPINF1 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
|
|
| G
|
Sesn2
|
sestrin 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of SESN2 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
|
|
| G
|
Sfn
|
stratifin
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SFN mRNA
|
CTD |
PMID:19167416 PMID:22213190 |
|
NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995
|
|
| G
|
Sirt1
|
sirtuin 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SIRT1 protein
|
CTD |
PMID:19167416 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc15a5
|
solute carrier family 15, member 5
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of SLC15A5 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 4:172,609,293...172,702,893
Ensembl chr 4:172,608,999...172,702,893
|
|
| G
|
Slc16a10
|
solute carrier family 16 member 10
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of SLC16A10 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr20:45,014,229...45,122,392
Ensembl chr20:45,014,235...45,122,358
|
|
| G
|
Slc25a4
|
solute carrier family 25 member 4
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of SLC25A4 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:52,805,523...52,811,700
|
|
| G
|
Slc2a8
|
solute carrier family 2 member 8
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SLC2A8 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 3:36,672,589...36,682,206
Ensembl chr 3:36,672,591...36,682,194
|
|
| G
|
Slc40a1
|
solute carrier family 40 member 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SLC40A1 mRNA
|
CTD |
PMID:21785164 |
|
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460
|
|
| G
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of SLCO1A4 mRNA
|
CTD |
PMID:16158176 |
|
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
|
|
| G
|
Slco1b2
|
solute carrier organic anion transporter family member 1B2
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of SLCO1B2 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of SLCO1B2 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
|
|
| G
|
Smad2
|
SMAD family member 2
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD2 protein; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD2 protein]
|
CTD |
PMID:15368444 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
| G
|
Smad3
|
SMAD family member 3
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD3 protein; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:15368444 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Smad4
|
SMAD family member 4
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of SMAD4 mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684
|
|
| G
|
Smo
|
smoothened, frizzled class receptor
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SMO mRNA
|
CTD |
PMID:17187413 |
|
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:59,311,041...59,341,281
|
|
| G
|
Sncg
|
synuclein, gamma
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SNCG mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr16:9,706,765...9,712,072
Ensembl chr16:9,706,753...9,712,076
|
|
| G
|
Sntg2
|
syntrophin, gamma 2
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of SNTG2 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 6:52,529,481...52,730,972
Ensembl chr 6:52,529,481...52,730,972
|
|
| G
|
Socs1
|
suppressor of cytokine signaling 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SOCS1 mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of SOD1 protein
|
CTD |
PMID:17761372 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of and results in increased activity of SOD2 protein; O-(Chloroacetylcarbamoyl)fumagillol inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of and results in increased activity of SOD2 protein]
|
CTD |
PMID:17761372 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sox4
|
SRY-box transcription factor 4
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SOX4 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,875,756...35,884,024
|
|
| G
|
Spink1
|
serine peptidase inhibitor, Kazal type 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of SPINK1 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr18:36,121,626...36,133,596
Ensembl chr18:36,076,399...36,133,545
|
|
| G
|
Sprr1a
|
small proline-rich protein 1A
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of SPRR1A mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 2:180,750,709...180,752,625
Ensembl chr 2:180,750,709...180,752,991
|
|
| G
|
Sprr2f
|
small proline rich protein 2F
|
increases expression multiple interactions
|
ISO
|
2-Acetylaminofluorene results in increased expression of SPRR2F mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SPRR2F mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 2:180,685,587...180,685,817
Ensembl chr 2:180,685,587...180,685,817
|
|
| G
|
Sptlc2
|
serine palmitoyltransferase, long chain base subunit 2
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of SPTLC2 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 6:112,679,623...112,762,470
Ensembl chr 6:112,679,623...112,762,640
|
|
| G
|
Sst
|
somatostatin
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of SST protein
|
CTD |
PMID:16534498 |
|
NCBI chr11:90,461,546...90,462,823
Ensembl chr11:90,461,546...90,462,823
|
|
| G
|
St3gal3
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of ST3GAL3 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 5:136,755,780...136,958,081
Ensembl chr 5:136,755,678...136,955,987
|
|
| G
|
St3gal5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of ST3GAL5 protein
|
CTD |
PMID:6331524 |
|
NCBI chr 4:105,692,840...105,750,774
Ensembl chr 4:105,692,840...105,750,775
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of STAT3 protein; Dexamethasone inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of STAT3 protein]
|
CTD |
PMID:12957465 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Steap3
|
STEAP3 metalloreductase
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of STEAP3 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr13:33,904,710...33,950,100
Ensembl chr13:33,904,710...33,950,080
|
|
| G
|
Stmn1
|
stathmin 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of STMN1 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842
|
|
| G
|
Sugct
|
succinylCoA:glutarate-CoA transferase
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of SUGCT mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr17:52,072,012...52,929,852
Ensembl chr17:52,072,052...52,930,281
|
|
| G
|
Sulf2
|
sulfatase 2
|
increases expression
|
EXP ISO
|
2-Acetylaminofluorene results in increased expression of SULF2 mRNA
|
CTD |
PMID:17070881 PMID:21607683 |
|
NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651
|
|
| G
|
Sult1c2a
|
sulfotransferase family 1C member 2A
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of SULT1C2 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 9:7,075,873...7,103,316
Ensembl chr 9:7,066,905...7,244,132
|
|
| G
|
Sult1e1
|
sulfotransferase family 1E member 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of SULT1E1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of SULT1E1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,700,292...20,718,716
|
|
| G
|
Sult2a1
|
sulfotransferase family 2A member 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of SULT2A1 mRNA
|
CTD |
PMID:17070881 |
|
NCBI chr 1:84,582,011...84,639,001
|
|
| G
|
Taldo1
|
transaldolase 1
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TALDO1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TALDO1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr 1:205,923,196...205,933,526
Ensembl chr 1:205,923,165...205,933,535
|
|
| G
|
Tceal9
|
transcription elongation factor A like 9
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TCEAL9 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TCEAL9 mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr X:104,037,274...104,039,345
Ensembl chr X:104,032,421...104,041,562
|
|
| G
|
Tes
|
testin LIM domain protein
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of TES mRNA
|
CTD |
PMID:21784091 |
|
NCBI chr 4:46,331,257...46,369,782
Ensembl chr 4:46,331,257...46,369,780
|
|
| G
|
Tf
|
transferrin
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of TF mRNA
|
CTD |
PMID:16510358 |
|
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400
|
|
| G
|
Tff1
|
trefoil factor 1
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TFF1 mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956
|
|
| G
|
Tff3
|
trefoil factor 3
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of TFF3 mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr20:9,194,623...9,199,333
Ensembl chr20:9,194,626...9,199,333
|
|
| G
|
Tfrc
|
transferrin receptor
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of TFRC mRNA
|
CTD |
PMID:21785164 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions increases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TGFB1 protein; IFNA2 protein promotes the reaction [[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TGFB1 protein] 2-Acetylaminofluorene results in increased expression of TGFB1 mRNA
|
CTD |
PMID:15368444 PMID:15940639 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
increases activity
|
ISO
|
2-Acetylaminofluorene results in increased activity of THRB protein
|
CTD |
PMID:31077750 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
| G
|
Thy1
|
Thy-1 cell surface antigen
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of THY1 protein
|
CTD |
PMID:17576600 |
|
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of TIMP1 mRNA
|
CTD |
PMID:18678246 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Tkt
|
transketolase
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TKT mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TKT mRNA
|
CTD |
PMID:14656948 PMID:16158176 |
|
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
|
|
| G
|
Tmem134
|
transmembrane protein 134
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of TMEM134 mRNA
|
CTD |
PMID:17317680 |
|
NCBI chr 1:210,848,761...210,857,735
Ensembl chr 1:210,848,578...210,858,861
|
|
| G
|
Tmem184c
|
transmembrane protein 184C
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of TMEM184C mRNA
|
CTD |
PMID:21784091 |
|
NCBI chr19:47,249,403...47,265,502
Ensembl chr19:47,249,500...47,265,949
|
|
| G
|
Tmem43
|
transmembrane protein 43
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of TMEM43 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr 4:125,534,844...125,549,986
Ensembl chr 4:125,534,813...125,549,988
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TNF protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of TNF protein]
|
CTD |
PMID:18271918 PMID:23665045 PMID:25051504 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Top2a
|
DNA topoisomerase II alpha
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of TOP2A mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression decreases expression increases response to substance multiple interactions
|
EXP ISO
|
2-Acetylaminofluorene results in increased expression of TP53 protein 2-Acetylaminofluorene results in increased expression of TRP53 protein 2-Acetylaminofluorene results in decreased expression of TP53 protein TRP53 protein modified form results in increased susceptibility to 2-Acetylaminofluorene TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of BAX mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CCNB2 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CDKN1A mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of EI24 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PERP mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PMAIP1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of RPRM mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of SERPINB5 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of ZMAT3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of CYP4F15 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of MEG3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of SLC25A4 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of TTR mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ALDH3A1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ANXA3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of AREG mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of COL17A1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1B1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of HEBP2 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT15 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT23 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of KRT4 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of LYPD3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of NOS3 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of PADI2 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of PMAIP1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SLC2A8 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of SPRR2F mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TFF1 mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TSHB mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TUBA1C mRNA]; TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of UBE2C mRNA] [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of TP53 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of TP53 protein; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of TP53 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TP53 protein; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of TP53 protein]; IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of TP53 protein]; Vanadium promotes the reaction [2-Acetylaminofluorene results in increased expression of TP53 protein]
|
CTD |
PMID:7728945 PMID:9667752 PMID:10708481 PMID:11003613 PMID:11915028 PMID:12888115 PMID:14633663 PMID:15565650 PMID:17317680 PMID:19167416 PMID:23665045 More...
|
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tp53inp1
|
tumor protein p53 inducible nuclear protein 1
|
multiple interactions increases expression
|
EXP ISO
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of TRP53INP1 mRNA; [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of TRP53INP1 mRNA 2-Acetylaminofluorene results in increased expression of TP53INP1 mRNA 2-Acetylaminofluorene results in increased expression of TRP53INP1 mRNA
|
CTD |
PMID:14656948 PMID:16158176 PMID:21607683 PMID:22584684 |
|
NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484
|
|
| G
|
Tp73
|
tumor protein p73
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of TP73 mRNA
|
CTD |
PMID:22213190 |
|
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:169,903,801...169,963,552
|
|
| G
|
Trpm2
|
transient receptor potential cation channel, subfamily M, member 2
|
multiple interactions
|
EXP
|
[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TRPM2 mRNA
|
CTD |
PMID:16158176 |
|
NCBI chr20:10,703,190...10,752,795
Ensembl chr20:10,704,482...10,752,802
|
|
| G
|
Tsc22d1
|
TSC22 domain family, member 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of TSC22D1 mRNA
|
CTD |
PMID:15089088 |
|
NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322
|
|
| G
|
Tshb
|
thyroid stimulating hormone subunit beta
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TSHB mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984
|
|
| G
|
Ttr
|
transthyretin
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in decreased expression of TTR mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr18:12,216,684...12,225,972
Ensembl chr18:12,216,732...12,225,969
|
|
| G
|
Tuba1c
|
tubulin, alpha 1C
|
multiple interactions
|
ISO
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of TUBA1C mRNA]
|
CTD |
PMID:17317680 |
|
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
|
|
| G
|
Tubb4b
|
tubulin, beta 4B class IVb
|
increases expression
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of TUBB4B mRNA
|
CTD |
PMID:21607683 PMID:22584684 |
|
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719
|
|
| G
|
Tubb5
|
tubulin, beta 5 class I
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of TUBB5 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726
|
|
| G
|
Tubb6
|
tubulin, beta 6 class V
|
increases expression
|
ISO
|
2-Acetylaminofluorene results in increased expression of TUBB6 mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr18:63,213,287...63,222,926
Ensembl chr18:63,213,279...63,224,303
|
|
| G
|
Ube2c
|
ubiquitin-conjugating enzyme E2C
|
increases expression multiple interactions
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of UBE2C mRNA TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of UBE2C mRNA]
|
CTD |
PMID:17317680 PMID:22584684 |
|
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678
|
|
| G
|
Ugt1a9
|
UDP glucuronosyltransferase family 1 member A9
|
increases glucuronidation
|
ISO
|
UGT1A9 protein results in increased glucuronidation of 2-Acetylaminofluorene analog
|
CTD |
PMID:11375903 |
|
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
increases expression
|
ISO EXP
|
2-Acetylaminofluorene results in increased expression of VCAM1 mRNA 2-Acetylaminofluorene results in increased expression of VCAM1 protein
|
CTD |
PMID:21607683 PMID:25051504 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
decreases expression multiple interactions increases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of VEGFA mRNA geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of VEGFA protein]
|
CTD |
PMID:22213190 PMID:25051504 PMID:26364502 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Wee1
|
WEE1 G2 checkpoint kinase
|
increases expression
|
EXP
|
2-Acetylaminofluorene results in increased expression of WEE1 mRNA
|
CTD |
PMID:22584684 |
|
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449
|
|
| G
|
Wwox
|
WW domain-containing oxidoreductase
|
decreases expression
|
ISO
|
2-Acetylaminofluorene results in decreased expression of WWOX mRNA
|
CTD |
PMID:21607683 |
|
NCBI chr19:59,338,402...60,269,323
Ensembl chr19:59,341,233...60,269,441
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
increases activity multiple interactions
|
EXP
|
2-Acetylaminofluorene results in increased activity of XDH protein Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of XDH protein]
|
CTD |
PMID:23665045 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
| G
|
Xpc
|
XPC complex subunit, DNA damage recognition and repair factor
|
decreases response to substance
|
ISO
|
XPC protein results in decreased susceptibility to 2-Acetylaminofluorene
|
CTD |
PMID:23153559 |
|
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305
|
|
| G
|
Zeb1
|
zinc finger E-box binding homeobox 1
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of ZEB1 protein
|
CTD |
PMID:19167416 |
|
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745
|
|
| G
|
Zeb2
|
zinc finger E-box binding homeobox 2
|
decreases expression
|
EXP
|
2-Acetylaminofluorene results in decreased expression of ZEB2 protein
|
CTD |
PMID:19167416 |
|
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
|
|
| G
|
Zmat3
|
zinc finger, matrin type 3
|
multiple interactions increases expression
|
ISO EXP
|
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of ZMAT3 mRNA] 2-Acetylaminofluorene results in increased expression of ZMAT3 mRNA
|
CTD |
PMID:17070881 PMID:17317680 PMID:19167416 PMID:21607683 PMID:22584684 |
|
NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294
|
|
|
|
| G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
EXP
|
[Acetoxyacetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of TP53 protein
|
CTD |
PMID:10741303 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
increases expression
|
EXP
|
Hydroxyacetylaminofluorene results in increased expression of ABCB1B mRNA; Hydroxyacetylaminofluorene results in increased expression of ABCB1B protein
|
CTD |
PMID:22084566 |
|
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567
|
|
| G
|
Nat1
|
N-acetyltransferase 1
|
decreases activity
|
ISO
|
Hydroxyacetylaminofluorene results in decreased activity of NAT1 protein
|
CTD |
PMID:19842618 |
|
NCBI chr16:26,984,882...27,005,194
Ensembl chr16:26,982,625...26,986,527
|
|
| G
|
Nat2
|
N-acetyltransferase 2
|
decreases activity
|
ISO
|
Hydroxyacetylaminofluorene results in decreased activity of NAT2 protein
|
CTD |
PMID:19842618 |
|
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
|
|
| G
|
Sult2a1
|
sulfotransferase family 2A member 1
|
increases sulfation
|
ISO
|
SULT2A1 protein results in increased sulfation of Hydroxyacetylaminofluorene
|
CTD |
PMID:10752640 |
|
NCBI chr 1:84,582,011...84,639,001
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression
|
EXP
|
Hydroxyacetylaminofluorene results in increased expression of TP53 protein
|
CTD |
PMID:9163691 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|